Eli Lilly's quarter was messy. What to do with the stock is more clear-cut

• Jim Cramer looks at what to do with Eli Lilly, AMD shares after their big slides on earnings

  Business - CNBC - 6 hours ago

• Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?

  Business - MarketWatch - 2 hours ago

• Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

  Business - CNBC - 1 hour ago

• Eli Lilly to trial use of weight loss drugs to combat unemployment in UK

  Business - CNBC - October 15
• 

  Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.

  Top stories - NBC News - October 16

More from CNBC

• Meta misses on user growth, warns of 2025 jump in AI spending

  Business - CNBC - 8 minutes ago

• Microsoft beats on top and bottom lines, driven by better-than-expected cloud growth

  Business - CNBC - 31 minutes ago

• Starbucks CEO pledges to fundamentally change strategy as sales fall for third straight quarter

  Business - CNBC - 57 minutes ago

• Starbucks will stop charging extra for dairy substitutes

  Business - CNBC - 11 minutes ago

• Carvana raises 2024 earnings guidance after topping Wall Street's Q3 expectations

  Business - CNBC - 50 minutes ago